ALTIUM CAPITAL MANAGEMENT LP Karyopharm Therapeutics Inc. Transaction History

ALTIUM CAPITAL MANAGEMENT LP portfolio value:

$4.09M
portfolio value

ALTIUM CAPITAL MANAGEMENT LP quarter portfolio value change:

+21.06%
quarter

Karyopharm Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +7.14% 50K shares 938K $5.46 750K
Q2 2022 share Increase +8.53% 55K shares -1.59M $4.51 700K
Q1 2022 share Increase 0.00% 645K shares 4.75M $7.37 645K
Q1 2021 share Decrease -100.00% -133.95K shares -2.07M $10.52 0
Q4 2020 share Increase 0.00% 133.95K shares 2.07M $15.48 133.95K